TWC
ZYNE

TD Waterhouse Canada’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

TD Waterhouse Canada’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,145
Closed -$1.73K – 1821
2023
Q2 		$1.73K Buy
+4,145
New +$1.49K ﹤0.01% 1552

Other funds holding ZYNE

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TD Waterhouse Canada's ZYNE Position: Q3 2023 in Review

TD Waterhouse Canada sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2023, closing a stake of 4,145 shares — an estimated $1.73K sold.

TD Waterhouse Canada first reported a position in ZYNE in Q2 2023 and held it in 1 quarter. The position peaked at $1.73K in Q2 2023. 43 funds tracked by Wall St. Rank hold ZYNE as of Q3 2023.

  • TD Waterhouse Canada reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2023 after selling out during the quarter.
  • TD Waterhouse Canada sold 4,145 Zynerba Pharmaceuticals, Inc shares in Q3 2023, an estimated $1.73K.
  • TD Waterhouse Canada first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2023 and held it in 1 quarter.
  • TD Waterhouse Canada's Zynerba Pharmaceuticals, Inc position peaked at $1.73K in Q2 2023.
  • 43 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2023.

Based on TD Waterhouse Canada's 13F filing for Q3 2023, filed 13 Nov 2023.